Expression of myf genes in rhabdomyosarcomas
Author Information
Author(s): J. Clark, P.J. Rocques, T. Braun, E. Bober, H.H. Arnold, C. Fisher, C. Fletcher, K. Brown, B.A. Gusterson, R.L. Carter, C.S. Cooper
Primary Institution: Haddow Laboratories, Institute of Cancer Research
Hypothesis
Can the expression of myf genes be used as a marker for diagnosing rhabdomyosarcoma?
Conclusion
The study found that myf genes are expressed in a high proportion of rhabdomyosarcomas, suggesting they could be useful in diagnosis.
Supporting Evidence
- 85% of rhabdomyosarcomas expressed the myf3 gene.
- 70% of rhabdomyosarcomas expressed the myf4 gene.
- 55% of rhabdomyosarcomas expressed the myf5 gene.
- 28% of rhabdomyosarcomas expressed the myf6 gene.
- Expression of myf genes was not detected in other types of paediatric tumours.
Takeaway
This study looked at how certain genes are found in a type of cancer called rhabdomyosarcoma, and they found that most of these cancers have these genes, which could help doctors tell if someone has this cancer.
Methodology
Northern analysis of tumour RNA was used to examine the expression of myf genes in rhabdomyosarcomas.
Limitations
The study had a small sample size and did not find myf gene expression in all types of rhabdomyosarcomas.
Participant Demographics
The majority of rhabdomyosarcomas were from children under 15 years old.
Want to read the original?
Access the complete publication on the publisher's website